BELGRADE, Mont., May 17, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that its Chief Executive Officer, Dan Goldberger will be presenting at the following conferences:
17th Annual B. Riley & Co. Investor Conference
The Company will be presenting at the 17th Annual B. Riley & Co. Investor Conference, to be held May 25 - 26, 2016 at the Loews Hollywood Hotel in Los Angeles, California. Xtant Medical's presentation will take place Wednesday, May 25, 2016 at 10:30 AM Pacific Time.
Marcum Microcap Conference
The Company will be presenting at the Marcum Micro-cap Conference, to be held June 1 - 2, 2016 at the Grand Hyatt in New York City, NY. Xtant Medical's presentation will take place Wednesday, June 1, 2016 at 11:00 AM Eastern Time.
LD Micro Conference
The Company will be presenting at the LD Micro Conference, to be held June 7 - 9, 2016 at the Luxe Sunset Bel Air, in Los Angeles, CA. Xtant Medical's presentation will take place Wednesday, June 8, 2016 at 10:30 AM Pacific Time.
A live broadcast of the B. Riley Conference and LD Micro conference presentation will be available.
To access the broadcast, go to the "Investor Info" section of the Company's website at www.xtantmedical.com. A replay of the conference presentation will also be available.
About Xtant Medical Holdings
Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) is a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
Important Cautions Regarding Forward-looking Statements
This press release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability to successfully integrate the acquisition of X-spine; the ability of the Company's sales force to achieve expected results, the Company's ability to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the Company's secured lending facility; the Company's ability to manage cash flow; the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
Source:Xtant Medical Holdings, Inc.